These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20631120)

  • 1. Development of a targeted gene vector platform based on simian adenovirus serotype 24.
    Belousova N; Mikheeva G; Xiong C; Soghomonian S; Young D; Le Roux L; Naff K; Bidaut L; Wei W; Li C; Gelovani J; Krasnykh V
    J Virol; 2010 Oct; 84(19):10087-101. PubMed ID: 20631120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid strategy for constructing novel simian adenovirus vectors with high viral titer and expressing highly antigenic proteins applicable for vaccine development.
    Luo S; Zhang P; Ma X; Wang Q; Lu J; Liu B; Zhao W; Allain JP; Li C; Li T
    Virus Res; 2019 Jul; 268():1-10. PubMed ID: 31108113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
    Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
    J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses.
    Bradshaw AC; Coughlan L; Miller AM; Alba R; van Rooijen N; Nicklin SA; Baker AH
    J Control Release; 2012 Dec; 164(3):394-402. PubMed ID: 22626939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.
    Harvey BG; Hackett NR; El-Sawy T; Rosengart TK; Hirschowitz EA; Lieberman MD; Lesser ML; Crystal RG
    J Virol; 1999 Aug; 73(8):6729-42. PubMed ID: 10400771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an adenoviral vaccine vector based on simian adenovirus 21.
    Roy S; Zhi Y; Kobinger GP; Figueredo J; Calcedo R; Miller JR; Feldmann H; Wilson JM
    J Gen Virol; 2006 Sep; 87(Pt 9):2477-2485. PubMed ID: 16894185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of adenovirus serotype 35 as a gene transfer vector.
    Seshidhar Reddy P; Ganesh S; Limbach MP; Brann T; Pinkstaff A; Kaloss M; Kaleko M; Connelly S
    Virology; 2003 Jul; 311(2):384-93. PubMed ID: 12842627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus vectors composed of subgroup B adenoviruses.
    Sakurai F; Kawabata K; Mizuguchi H
    Curr Gene Ther; 2007 Aug; 7(4):229-38. PubMed ID: 17969556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy.
    Breidenbach M; Rein DT; Wang M; Nettelbeck DM; Hemminki A; Ulasov I; Rivera AR; Everts M; Alvarez RD; Douglas JT; Curiel DT
    Hum Gene Ther; 2004 May; 15(5):509-18. PubMed ID: 15144580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and assessment of human adenovirus type 11 as a gene transfer vector.
    Stone D; Ni S; Li ZY; Gaggar A; DiPaolo N; Feng Q; Sandig V; Lieber A
    J Virol; 2005 Apr; 79(8):5090-104. PubMed ID: 15795294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.
    Alba R; Bradshaw AC; Coughlan L; Denby L; McDonald RA; Waddington SN; Buckley SM; Greig JA; Parker AL; Miller AM; Wang H; Lieber A; van Rooijen N; McVey JH; Nicklin SA; Baker AH
    Blood; 2010 Oct; 116(15):2656-64. PubMed ID: 20610817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions.
    Bradley RR; Maxfield LF; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
    J Virol; 2012 Jan; 86(2):1267-72. PubMed ID: 22072746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.
    Mack CA; Song WR; Carpenter H; Wickham TJ; Kovesdi I; Harvey BG; Magovern CJ; Isom OW; Rosengart T; Falck-Pedersen E; Hackett NR; Crystal RG; Mastrangeli A
    Hum Gene Ther; 1997 Jan; 8(1):99-109. PubMed ID: 8989999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
    Dicks MD; Spencer AJ; Edwards NJ; Wadell G; Bojang K; Gilbert SC; Hill AV; Cottingham MG
    PLoS One; 2012; 7(7):e40385. PubMed ID: 22808149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
    Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
    Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
    Ma J; Duffy MR; Deng L; Dakin RS; Uil T; Custers J; Kelly SM; McVey JH; Nicklin SA; Baker AH
    PLoS Pathog; 2015 Feb; 11(2):e1004673. PubMed ID: 25658827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.
    Bruder JT; Chen P; Semenova E; Thomas CA; Konovalova S; Ekberg G; Ettyreddy D; McVey D; Gall JG; King CR; Brough DE
    J Virol; 2013 Sep; 87(17):9661-71. PubMed ID: 23824800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.
    Mastrangeli A; Harvey BG; Yao J; Wolff G; Kovesdi I; Crystal RG; Falck-Pedersen E
    Hum Gene Ther; 1996 Jan; 7(1):79-87. PubMed ID: 8825871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity.
    Krutzke L; Prill JM; Engler T; Schmidt CQ; Xu Z; Byrnes AP; Simmet T; Kreppel F
    J Control Release; 2016 Aug; 235():379-392. PubMed ID: 27302248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse adenovirus type 1 and human adenovirus type 5 differ in endothelial cell tropism and liver targeting.
    Lenaerts L; McVey JH; Baker AH; Denby L; Nicklin S; Verbeken E; Naesens L
    J Gene Med; 2009 Feb; 11(2):119-27. PubMed ID: 19065608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.